Moderna https://www.reuters.com/markets/companies/MRNA.O” target=”_blank” rel=”noopener”>(MRNA.O) said on Tuesday it will cut production of mRNA drug substance for its COVID-19 vaccine at Lonza’s https://www.reuters.com/markets/companies/LONN.S” target…
Read More
About The Author
